Procollagen type III N-terminal peptide (P3NP) and lean mass: a cross-sectional study.
about
Biomarkers for physical frailty and sarcopenia: state of the science and future developmentsHigh serum N-terminal propeptide of procollagen type III concentration is associated with liver diseases.Leucine and ACE inhibitors as therapies for sarcopenia (LACE trial): study protocol for a randomised controlled trial.Prediction of sarcopenia using a combination of multiple serum biomarkers.
P2860
Procollagen type III N-terminal peptide (P3NP) and lean mass: a cross-sectional study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Procollagen type III N-terminal peptide (P3NP) and lean mass: a cross-sectional study.
@en
Procollagen type III N-terminal peptide
@nl
type
label
Procollagen type III N-terminal peptide (P3NP) and lean mass: a cross-sectional study.
@en
Procollagen type III N-terminal peptide
@nl
prefLabel
Procollagen type III N-terminal peptide (P3NP) and lean mass: a cross-sectional study.
@en
Procollagen type III N-terminal peptide
@nl
P2093
P2860
P1476
Procollagen type III N-terminal peptide (P3NP) and lean mass: a cross-sectional study.
@en
P2093
Douglas P Kiel
Peggy M Cawthon
Philimon Gona
Robert R McLean
Sarah D Berry
P2860
P304
P577
2013-01-01T00:00:00Z